Orchid Pharma reports standalone net loss of Rs 34.75 crore in the December 2019 quarter

Capital Market 

Sales decline 13.38% to Rs 128.58 crore

Net Loss of Orchid Pharma reported to Rs 34.75 crore in the quarter ended December 2019 as against net loss of Rs 18.47 crore during the previous quarter ended December 2018. Sales declined 13.38% to Rs 128.58 crore in the quarter ended December 2019 as against Rs 148.45 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales128.58148.45 -13 OPM %-7.038.42 -PBDT-3.1114.37 PL PBT-34.75-18.47 -88 NP-34.75-18.47 -88

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, February 18 2020. 09:12 IST